Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study
Preferences for different insomnia treatment options in people with schizophrenia and related psychoses: a qualitative study
复制标题
精神分裂症和相关精神病患者对不同失眠治疗方案的偏好：一项定性研究
作者：
F. Waters;V. Chiu;A. Janča;A. Atkinson;M. Ree
精神病的症状，如幻觉和妄想，可能是侵入性的和不必要的，往往仍然是治疗抵抗。由于基础和临床科学的最新进展，越来越多的新方法，如基于睡眠的干预措施，以解决严重精神疾病患者的身心健康问题。虽然主要结果是改善睡眠，但研究表明，针对失眠症状的干预措施也可以改善精神病症状的严重程度，生活质量和功能结果。本研究提供了精神分裂症和情感障碍患者对三种不同类型的失眠治疗（标准药理学、基于褪黑激素和认知和/或行为治疗）的态度和偏好的定性数据。访谈包括讨论不同疗法的优势和局限性，采取首选方案的推动因素，以及过去帮助受访者解决睡眠问题的个人策略。结果表明，当给予选择时，这些人更喜欢心理和行为类型的治疗，而不是其他睡眠干预措施，因为它有可能支持和授权他们为自己的恢复负责。相比之下，药物治疗被认为是有效的管理急性睡眠问题，但只是作为一个短期的解决方案。总的来说，研究结果强调了患者在决定治疗方案时的积极参与。
Symptoms of psychosis such as hallucinations and delusions can be intrusive and unwanted and often remain treatment-resistant. Due to recent progress in basic and clinical sciences, novel approaches such as sleep-based interventions are increasingly becoming offered to address the physical and mental health issues of people with severe mental illness. While the primary outcome is to improve sleep, studies have demonstrated that interventions that target symptoms of insomnia can also produce improvements in the severity of psychotic symptoms, quality of life, and functional outcomes. This study presents qualitative data on the attitudes and preferences of people with schizophrenia and schizo-affective disorders to three different types of therapies for insomnia (standard pharmacological, melatonin-based, and cognitive and/or behavior therapy). Interviews included discussions regarding the perceived advantages and limitations of different therapies, enablers to taking up the preferred option, as well as personal strategies that have helped respondents with sleep problems in the past. Results showed that, when given the choice, these individuals prefer psychological and behavioral-type therapy to other sleep interventions because of its potential to support and empower them in taking responsibility for their own recovery. Pharmacological therapies, by contrast, are viewed as useful in managing acute sleep problems, but only as a short-term solution. Overall, the findings underscore the need for patients’ active engagement when making decisions about treatment options.
登录
查看更多内容
影响因子：
--
作者：
E. Cauter;Paul Linkowski;Myriam Kerkhofs;P. Hubain;M. L’Hermite‐Balériaux;Raoul Leclercq;Michelle Brasseur;Georges Copinschi;Julien Mendlewicz
通讯作者：
E. Cauter;Paul Linkowski;Myriam Kerkhofs;P. Hubain;M. L’Hermite‐Balériaux;Raoul Leclercq;Michelle Brasseur;Georges Copinschi;Julien Mendlewicz
影响因子：
158.5
作者：
Lieberman, JA;Stroup, TS;Hsiao, JK
通讯作者：
Hsiao, JK
影响因子：
5.9
作者：
Harvey AG;Bélanger L;Talbot L;Eidelman P;Beaulieu-Bonneau S;Fortier-Brochu É;Ivers H;Lamy M;Hein K;Soehner AM;Mérette C;Morin CM
通讯作者：
Morin CM
精神分裂症复发前驱症状的前瞻性研究。
DOI：
10.1176/ajp.142.3.371
发表时间：
1985
期刊：
The American journal of psychiatry
影响因子：
--
作者：
Heinrichs,DW;CarpenterJr,WT
通讯作者：
CarpenterJr,WT